JP Patent

JP5805802B2 — 体液貯留または塩分過負荷と関連する障害および消化管障害の治療におけるｎｈｅ媒介性アンチポートを阻害するための組成物および方法

Assigned to アーデリクス，インコーポレーテッド · Expires 2015-11-10 · 11y expired

What this patent protects

Patent listed against tenapanor-hydrochloride.

Drugs covered by this patent

tenapanor-hydrochloride (TENAPANOR HYDROCHLORIDE)

Patent Metadata

Patent number: JP5805802B2
Jurisdiction: JP
Classification: —
Expires: 2015-11-10
Drug substance claim: No
Drug product claim: No
Assignee: アーデリクス，インコーポレーテッド
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.